Breaking News
April 18, 2019 - Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
April 18, 2019 - Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
April 18, 2019 - Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
April 18, 2019 - Adhesive gel bonds to eye surface, could repair injuries without surgery
April 18, 2019 - The future of genomics: A podcast featuring Stanford geneticists
April 18, 2019 - As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
April 18, 2019 - APOE gene impacts sleep depending on gender and severity of Alzheimer’s
April 18, 2019 - PCORI’s newly approved awards focus on cancer pain and opioid use disorders
April 18, 2019 - New tool provides a standard way to measure effects of caring for survivors of TBI
April 18, 2019 - Smartphone use risks eye examination misdiagnosis
April 18, 2019 - How drug-resistant bugs grow in CF patients’ lungs
April 18, 2019 - Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
April 18, 2019 - Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
April 18, 2019 - Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
April 18, 2019 - New estimation method assesses natural variations in sex ratio at birth
April 18, 2019 - UTA scientist receives $1.17 million grant for cancer research
April 18, 2019 - Coagulation factor VIIa prevents bleeds in hemophilia animal models
April 18, 2019 - Researchers identify risk factors for severe infection after knee replacement
April 18, 2019 - Mass drug administration can offer community-level protection against malaria
April 18, 2019 - FDA’s added sugar label could have substantial health and cost-saving benefits
April 18, 2019 - Researchers identify cause of inherited metabolic disorder
April 18, 2019 - Single strip of white paint not sufficient to protect people who ride bikes
April 18, 2019 - Partner status influences link between sexual problems and self-efficacy in breast cancer survivors
April 18, 2019 - Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
April 18, 2019 - Rigid spine muscular dystrophy – Genetics Home Reference
April 18, 2019 - Simple bile acid blood test could tell risk of stillbirth
April 18, 2019 - Center for Experimental Therapeutics aims to enable all steps of drug development | News Center
April 18, 2019 - Falling for telephone scams could be an early sign of dementia
April 18, 2019 - Researchers annotate key neuronal proteins in lamprey genome
April 18, 2019 - Study uncovers new biomarker for personalized cancer treatments
April 18, 2019 - Scientists enter research collaboration to find a cure for cancer
April 18, 2019 - Study to compare benefits of tai chi and mindfulness meditation on MS symptoms
April 18, 2019 - Gestational diabetes during pregnancy may increase risk of type 1 diabetes in children
April 18, 2019 - Is a New Remedy for Body Odor on the Horizon?
April 18, 2019 - Orthostatic hypotension – Genetics Home Reference
April 18, 2019 - Healing the heartbreak of stillbirth and newborn death
April 18, 2019 - Conference to highlight advances in human immune monitoring, bioinformatics | News Center
April 18, 2019 - Bacteria use viruses for self-recognition, study reveals
April 18, 2019 - New adhesive patch could help reduce post-heart attack muscle damage
April 18, 2019 - Researchers analyze the effects of dark play in a serious video game
April 18, 2019 - Scientists revive pig brain cells four hours after death
April 18, 2019 - Filial cannibalism and offspring abandonment may be forms of parental care
April 18, 2019 - Two proteins act in concert to maintain a healthy heart in mice, shows study
April 18, 2019 - Scientists create a functioning 3D printed heart
April 18, 2019 - Non-invasive vagus nerve stimulation improves disease symptoms in patients with rheumatoid arthritis
April 18, 2019 - Majority of men struggle to understand diagnosis and treatment of prostate cancer
April 18, 2019 - Researchers create new small molecules that may combat equine encephalitis viruses
April 18, 2019 - Animal-assisted therapy improves social behavior in patients with brain injuries
April 18, 2019 - Some viruses help protect harmful bacteria in CF patients | News Center
April 18, 2019 - Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients
April 18, 2019 - Men who have a resting heart rate of 75 bpm are twice as likely to die early
April 18, 2019 - Novel serum biomarkers to detect NAFLD-related fibrosis
April 18, 2019 - New study delves deeper into individual genomic differences than ever before
April 18, 2019 - Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients
April 18, 2019 - Emotional mirror neurons found in rats
April 18, 2019 - Sylvia Plevritis appointed chair of biomedical data science | News Center
April 18, 2019 - Cervical cancer subtype increasing in several subpopulations of women
April 18, 2019 - Yeast strain provides manufacturing boost to low-calorie sweetener derived from lactose
April 18, 2019 - One in five children and youth suffer from a mental disorder
April 18, 2019 - Improper inhaler use common in children with asthma
April 18, 2019 - C-Path and CDISC release global Therapeutic Area Standard for HIV research
April 18, 2019 - Integrating AI to analyze imaging data allows early recognition of heart disease
April 18, 2019 - Low-cost, high-speed algorithm may allow animal-free chemical toxicity testing
April 18, 2019 - HPV-negative cervical cancers are more aggressive with worse prognosis
April 18, 2019 - AI detects prostate cancer with same level of accuracy as experienced radiologists
April 18, 2019 - Study resolves sex differences in psychiatric illness risk
April 18, 2019 - Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD
April 18, 2019 - Cocktail of common antibiotics can fight resistant E. coli
April 18, 2019 - Persis Drell to give keynote address at medical school diploma ceremony | News Center
April 18, 2019 - EpicTogether: Remembering Our Why
April 18, 2019 - Study identifies novel loci contributing to asthma susceptibility in adults
April 18, 2019 - Gut bacteria and pregnancy
April 18, 2019 - New study finds that screening could help prevent rare types of cervical cancer
April 17, 2019 - Spatial orgnization of the genome can be altered using small molecules
April 17, 2019 - AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients
April 17, 2019 - Telemedicine tied to more antibiotics for kids, study finds
April 17, 2019 - Two medical students awarded 2019 Soros Fellowships for New Americans | News Center
April 17, 2019 - Sociologist Constance A. Nathanson Awarded Guggenheim Fellowship
April 17, 2019 - Empathy and hormones could account for aggressive behavior in children, shows study
April 17, 2019 - Researchers develop oral appliance to help sufferers of sleep apnea
Empa researchers investigate the safety of graphene for humans

Empa researchers investigate the safety of graphene for humans

image_pdfDownload PDFimage_print

Graphene, a single layer of hexagonally arranged carbon atoms, is regarded as the miracle material of the future: it is flexible, transparent, strong, can assume different electrical properties and has the highest thermal conductivity of all known materials. This makes it extremely interesting for countless possible applications. Europe has recognized this as well: The large-scale research program “Graphene Flagship” has been running for five years and is dedicated to this material. It is the largest research initiative that Europe has launched to date – this shows the enormous importance of graphene.

Biological effects under the microscope

But despite all the euphoria: As with any new technology, the potential downsides have to be taken into account early on. In the past, these were often investigated too late. For example, asbestos, once appreciated for its fire retardant properties, was used in the early 20th century to manufacture numerous products – but health hazards were only gradually discovered. In 1970, asbestos fibres were officially classified as carcinogenic.

An important part of the graphene flagship is therefore dedicated to the question: Are graphene-based materials safe for humans and the environment? To this day, numerous studies have been carried out within the framework of the flagship. Empa researchers from the Particles-Biology Interactions Lab investigated for example how graphene oxide affects the human lung, gastrointestinal tract or placental barrier.

A comprehensive review article has now been published in the halfway stage of the graphene flagship project, which links the data produced within the framework of the major international research project with other published studies and thus shows the current state of knowledge on the subject of the safety of graphene-based materials. Partners from 15 European universities and research institutes participated in the review, including Empa researchers Peter Wick and Tina Bürki.

The article provides an overview of when parts of graphene-based materials can even enter the environment or the human body during their life cycle: during production, use, aging or in the disposal or recycling process. The majority of the studies evaluated were devoted to the question of how graphene-based materials interact with the human body. These include the different ways in which materials can enter the body, for example by inhalation, ingestion or skin contact, as well as the distribution and interaction with important organs such as the central nervous system, lungs, skin, immune system, cardiovascular system, gastrointestinal tract and reproductive system.

Structure determines activity

It’s noticeable: Not all studies come to the same result. However, this is not necessarily due to the fact that the quality of individual studies is poor: “The challenge is that not all graphene is the same,” explains Peter Wick, head of the Particles-Biology Interactions Lab at Empa. Graphene-based materials can consist of one or more layers, the width and length of the layer can vary, and the ratio of carbon to oxygen atoms can also differ.

Depending on the combination of these three parameters, not only do completely different material properties result – the effects on humans and the environment also vary greatly. This makes simple, generally valid statements almost impossible. “Our goal is therefore to create a detailed model for a relationship between structure and certain properties,” said Wick. Careful characterization of the materials studied is therefore central. In the future, self-learning algorithms could help to generate a model from the data in order to predict the biological effects of a certain graphene structure.

However, such a comprehensive model is still a dream of the future. “We see ourselves here as a kind of launch helper for determining the safety of graphene-based materials and products,” explains Wick. “Although there are more and more studies and thus indications of how graphene-based materials affect living systems, there are still gaps in our knowledge. These gaps need to be filled before we can make a clear prediction about how a graphene-based material with certain properties will affect biological systems.” The aim is to create a new standard for authorities, research and industry so that the miracle material graphene can also be used safely.

Graphene Flagship The Graphene Flagship is the EU’s biggest research initiative to date, and, according to the European Commission, ‘history’s greatest distinction for excellent research’. With a budget of EUR one billion, the Graphene Flagship is tasked with taking graphene from the realm of academic laboratories into European society in ten years – thus generating economic growth, new jobs and new opportunities for Europeans as both investors and employees. With the Graphene Flagship, Europe has launched a new form of joint, coordinated research initiative of unprecedented scale. Graphene Flagship brings together an academic-industrial consortium aiming at a breakthrough for technological innovation. The research effort will cover the entire value chain from materials production to components and system integration, and targets a number of specific goals that exploit the unique properties of graphene.

Source:

https://www.empa.ch/web/s604/graphene-safety

Tagged with:

About author

Related Articles